Search Results - Filip Rob

Efficacy and Safety Evaluation of Different Lebrikizumab Dosages in Atopic Dermatitis Patients Over 16 to 24 Weeks: A BIOREP Registry Analysis by Filip Rob, Martina Kojanová, Jana Třešnák Hercogová, Monika Baláž, Jiří Horažďovský, Yvetta Vantuchová, Marie Jandová, Kateřina Hrazdírová, Miroslav Nečas, David Stuchlík, Jan Říčař, Zdeněk Antal, Spyridon Gkalpakiotis

Get full text

Efficacy and safety of lebrikizumab in atopic dermatitis over 24 weeks: An analysis from the BIOREP registry by Filip Rob, Spyridon Gkalpakiotis, Martina Kojanová, Yvetta Vantuchová, Jarmila Čelakovská, Jiří Horažďovský, Monika Baláž, Miroslav Nečas, David Stuchlík, Petra Cetkovská, Kateřina Hrazdírová, Alena Machovcová, Blanka Pinková, Jana Třešňák Hercogová

Get full text

Efficacy, Safety, and Drug Survival During the First Year of Biologic Therapy for Psoriasis in Elderly Versus Younger Patients by Tereza Sobotkova, Jan Hugo, Miloslav Salavec, Martina Kojanova, Martin Tichy, Miroslav Necas, Alena Machovcova, Martin Cetkovsky, Zdenka Kysilka, Simona Tivadar, Simona Vachatova, Natalie Kunesova, Monika Balaz, Pavlina Prikrylova, Filip Rob

Get full text